Carlyle's bluebird Deep Discount Buyout (Rating Upgrade)
Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...
Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...
Business Insider21d
Agios to Present at Upcoming Investor Conferences
Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes ...
Insider Monkey10d
15 Best Biotech Stocks to Buy According to Billionaires
It has four approved medications for the treatment of cystic fibrosis (CF), and one approved treatment for transfusion-dependent beta-thalassemia ... type 1, and alpha-1 antitrypsin deficiency ...
Business Insider20d
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes ...
Leerink Partnrs Issues Positive Estimate for BEAM Earnings
Research analysts at Leerink Partnrs lifted their Q1 2025 earnings estimates for shares of Beam Therapeutics in a research ...
Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Beam Therapeutics (NASDAQ:BEAM) Earns Buy Rating from HC Wainwright
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright ...
Zacks Investment Research on MSN8d
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?
Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...
Frontiers10d
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
For beta-thalassemia carriers alone ... HPLC as the first step identified several types of hemoglobinopathies, including alpha and beta variants, that would have otherwise been missed by the ...